search
Back to results

Treatment Period and Long-term Effect of Functional Electric Stimulation (FES) for Bruxism

Primary Purpose

Bruxism

Status
Terminated
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Grindcare (Active)
Grindcare (Placebo - the device is not activated)
Sponsored by
Medotech A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Bruxism focused on measuring Bruxism, EMG, Biofeedback

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Signed and dated ICF
  • 18 years or older
  • Fulfill the RDC-criteria for myofascial TMD diagnose (group 1a or 1b)
  • Average pain more that 3 on a Visual Analog scale (VAS) in the baseline period

Exclusion Criteria:

  • Contraindication of concommitant diseases for the study judged by investigator
  • Daily use of pain medication, e.g. prophylaxis against migraine or headache.
  • Patients who are using occlusal splints in the treatment period.

Sites / Locations

  • Odontologisk Institut

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

24 patients receiving active treatment

Placebo treatment

Outcomes

Primary Outcome Measures

Primary outcome is to reduce the EMG activity per hour per night

Secondary Outcome Measures

Secondary outcome is to evaluate long-term effect of FES om EMG activity

Full Information

First Posted
December 9, 2008
Last Updated
October 20, 2009
Sponsor
Medotech A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT00807430
Brief Title
Treatment Period and Long-term Effect of Functional Electric Stimulation (FES) for Bruxism
Official Title
A Single Centre, Randomised, Clinical Placebo Controlled Study of the Optimal Treatment and Long-term Effect of FES on Bruxism
Study Type
Interventional

2. Study Status

Record Verification Date
October 2009
Overall Recruitment Status
Terminated
Study Start Date
February 2009 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
October 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Medotech A/S

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To investigate the effect of the treatment with Grindcare® on the muscles- and jaw symptoms and at the jaw muscle activity during sleep.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bruxism
Keywords
Bruxism, EMG, Biofeedback

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
24 patients receiving active treatment
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Placebo treatment
Intervention Type
Device
Intervention Name(s)
Grindcare (Active)
Intervention Description
Active treatment
Intervention Type
Device
Intervention Name(s)
Grindcare (Placebo - the device is not activated)
Intervention Description
Placebo treatment
Primary Outcome Measure Information:
Title
Primary outcome is to reduce the EMG activity per hour per night
Time Frame
10 weeks after start of treatment
Secondary Outcome Measure Information:
Title
Secondary outcome is to evaluate long-term effect of FES om EMG activity
Time Frame
after end of treatment with FES

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Signed and dated ICF 18 years or older Fulfill the RDC-criteria for myofascial TMD diagnose (group 1a or 1b) Average pain more that 3 on a Visual Analog scale (VAS) in the baseline period Exclusion Criteria: Contraindication of concommitant diseases for the study judged by investigator Daily use of pain medication, e.g. prophylaxis against migraine or headache. Patients who are using occlusal splints in the treatment period.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Troels B Mortensen
Organizational Affiliation
Medotech A/S
Official's Role
Study Director
Facility Information:
Facility Name
Odontologisk Institut
City
Aarhus C
ZIP/Postal Code
8000
Country
Denmark

12. IPD Sharing Statement

Learn more about this trial

Treatment Period and Long-term Effect of Functional Electric Stimulation (FES) for Bruxism

We'll reach out to this number within 24 hrs